Showing results (291-300 of 352) with videos related to
Sort By:
Pageof 36
BJU International|August 5, 2016
Renal fossa recurrence after nephrectomy for renal cell carcinoma: prognostic features and oncological outcomesSarah P Psutka, Mark Heidenreich, Stephen A Boorjian, et al.CBE Life Sciences Education|February 23, 2026
Can we Mitigate the Impacts of Test Anxiety Through Reappraisal Interventions? A Replication Study in Science Courses Across Multiple Institution Types in the United StatesRuben S Thormodsæter, Cissy J Ballen, Sheritta Fagbodun, et al.European Urology|May 27, 2017
Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched AnalysisBimal Bhindi, Igor Frank, Ross J Mason, et al.Urology|August 22, 2016
Complications and Outcomes Associated With Surgical Management of Renal Cell Carcinoma Involving the Liver: A Matched Cohort StudyDaniel D Joyce, Sarah P Psutka, Ryan T Groeschl, et al.European Urology|July 19, 2018
The Probability of Aggressive Versus Indolent Histology Based on Renal Tumor Size: Implications for Surveillance and TreatmentBimal Bhindi, R Houston Thompson, Christine M Lohse, et al.Journal of the National Comprehensive Cancer Network : JNCCN|February 11, 2026
Assessing the Current Stage of Burnout in Hematology-Oncology Faculty and Trainees- Is There a Path to Remission?Savannah S Liddell, Amye J Tevaarwerk, Brittany L Siontis, et al.Epilepsy Research|March 29, 2013
Routine polysomnography in an epilepsy monitoring unitMatthew C L Phillips, Craig A Costello, Elise J White, et al.The Journal of Urology|August 21, 2015
Decreased Skeletal Muscle Mass is Associated with an Increased Risk of Mortality after Radical Nephrectomy for Localized Renal Cell CancerSarah P Psutka, Stephen A Boorjian, Michael R Moynagh, et al.Investigational New Drugs|September 13, 2021
Phase I study of cediranib, an oral VEGFR inhibitor, in combination with selumetinib, an oral MEK inhibitor, in patients with advanced solid malignanciesJoleen M Hubbard, Jun Yin, Erin L Schenk, et al.International Journal of Molecular Sciences|November 4, 2017
Whole Blood mRNA Expression-Based Prognosis of Metastatic Renal Cell CarcinomaKarthik V Giridhar, Carlos P Sosa, David W Hillman, et al.Pageof 36